Information
- Information
Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in The Pharma Letter
- News Release
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to KYORIN Pharmaceutical
- Information
Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in Base to Base Biotech Podcast
- Information
Our Operating Officer & CSO, Tasuku Ishida, to Deliver an Invited Lecture at 3rd Targeted Protein Degradation Conference in Japan
- Information
Article on the Provision of Elix Discovery™ to Eisai Featured in FirstWord Pharma and AI BRIEF
- Information
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in BioPharmaTrend, AI BRIEF, and eCommerceNews
- Information
Article on the Commercialization of a Federated Learning-Based AI Drug Discovery Platform Featured in The Nikkei Biotech ONLINE, Nikkan Kogyo Shimbun Digital Edition, Biz/Zine, and AnswersNews
- News Release
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai
- News Release
Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies